🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal for this study is to evaluate up to 3 dose levels of mRNA-...
Status
Completed
Location
Children's of Alabama
Start Date
2021-03-15
Trial ID
NCT04796896
Treatments Being Tested
Part 1: An open label, dose and age escalation phase to evaluate the safety...
Status
Terminated
Location
Ark Clinical Research
Start Date
2021-10-22
Trial ID
NCT05067933
Treatments Being Tested
The goal of this clinical trial, on healthy volunteers, is to learn more ab...
Status
Recruiting
Location
Hopital Henri Mondor
Start Date
2024-05-27
Trial ID
NCT06255626
Treatments Being Tested
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
The purpose of this study (Part 1 and Part 2) is to evaluate the relative v...
Status
Completed
Location
Optimal Research
Start Date
2023-03-28
Trial ID
NCT05815498
Treatments Being Tested
The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease r...
Status
Completed
Location
Velocity Clinical Research - Banning
Start Date
2020-12-09
Trial ID
NCT04649151
Treatments Being Tested
The study evaluated the safety, tolerability, reactogenicity, and effective...
Status
Terminated
Location
Trinity Clinical Research, LLC - Bessemer
Start Date
2022-09-30
Trial ID
NCT05584202
Treatments Being Tested
Part 1: Primary Vaccination in Adults Part 1 will evaluate the safety and i...
Status
Completed
Location
The Health Centrum
Start Date
2022-01-31
Trial ID
NCT05084989
The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1...
Status
Completed
Location
Chandler Clinical Trials
Start Date
2023-04-14
Trial ID
NCT05827926
This is a 2-part study to evaluate the immunogenicity, safety, and reactoge...
Status
Completed
Location
Aberdeen Royal Infirmary - PPDS
Start Date
2022-02-16
Trial ID
NCT05249829
Treatments Being Tested